Chorea is a characteristic type of involuntary movement in Huntington’s disease. This movement is often described as a smooth, writhing, squirmy, or twisting motion. It can affect any part of ...

Read as part of the Discussion of Dr. H. E. Marion's paper before the Obstetrical Society of Boston Dec. 15, 1903.

Patients with Huntington's often receive anti-dopaminergic medications, such as neuroleptic medications or vesicular ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

Ingrezza (valbenazine) is a brand-name oral capsule prescribed for tardive dyskinesia and Huntington’s chorea. The cost of the drug with and without insurance can depend on several factors.

Xenazine (tetrabenazine) is a brand-name oral tablet that’s prescribed for chorea (a movement disorder) in people with Huntington’s disease. If you have problems with side effects from ...

These include helping infertile couples who have had no luck with other infertility treatments to have children or allowing a parent bearing a gene for a debilitating disease such as Huntington's ...

Ingrezza (valbenazine) is a prescription drug that’s used to treat tardive dyskinesia and chorea caused by Huntington’s disease. Ingrezza can cause mild to serious side effects. Examples ...

Qure's AMT-130 receives FDA Breakthrough Therapy designation for Huntington's disease, adding to Fast Track, RMAT, and Orphan ...

Huntington's disease (HD) is a hereditary neurodegenerative disorder ... The movement disorder is characterized by involuntary movements known as chorea, and by the impairment of voluntary movements.